Stock Earnings

Question 1

What are Silence Therapeutics PLC's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Silence Therapeutics PLC has a total asset of $0, Net loss of $0

Question 2

What are the key financial ratios for SLN?

Accepted Answer

Silence Therapeutics PLC's Current ratio is 0, has a Net margin is 0, sales per share of $0.

Question 3

How is Silence Therapeutics PLC's revenue broken down by segment or geography?

Accepted Answer

Silence Therapeutics PLC largest revenue segment is Ribonucleic Acid Therapeutics, at a revenue of 42,353,702 in the most earnings release.For geography, United Kingdom is the primary market for Silence Therapeutics PLC, at a revenue of 42,212,712.

Question 4

Is Silence Therapeutics PLC profitable?

Accepted Answer

no, according to the latest financial statements, Silence Therapeutics PLC has a net loss of $0

Question 5

Does Silence Therapeutics PLC have any liabilities?

Accepted Answer

no, Silence Therapeutics PLC has liability of 0

Question 6

How many outstanding shares for Silence Therapeutics PLC?

Accepted Answer

Silence Therapeutics PLC has a total outstanding shares of 0

Breakdown	TTM
Revenue	0
Revenue Growth (YoY)	-100%
Cost of Revenue	0
Gross Profit	0
Selling, General & Admin	21
Research & Development	56
Operating Expenses	79
Other Non Operating Income (Expenses)	8
Pretax Income	-75
Income Tax Expense	0
Net Income	-75
Net Income Growth	-41%
Shares Outstanding (Diluted)	141.7
Shares Change (YoY)	0%
EPS (Diluted)	-0.52
EPS Growth	-42%
Free Cash Flow	--
Free Cash Flow Per Share	--
Gross Margin	0%
Operating Margin	0%
Profit Margin	0%
Free Cash Flow Margin	--
EBITDA	--
EBITDA Margin	--
D&A For EBITDA	--
EBIT	-78
EBIT Margin	0%
Effective Tax Rate	0%

Silence Therapeutics PLC (SLN) Price

SLN Stock Price Chart

SLN Income

Follow-Up Questions